Literature DB >> 17632526

Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells.

Marco Idzko1, Hamida Hammad, Menno van Nimwegen, Mirjam Kool, Monique A M Willart, Femke Muskens, Henk C Hoogsteden, Werner Luttmann, Davide Ferrari, Francesco Di Virgilio, J Christian Virchow, Bart N Lambrecht.   

Abstract

Extracellular ATP serves as a danger signal to alert the immune system of tissue damage by acting on P2X or P2Y receptors. Here we show that allergen challenge causes acute accumulation of ATP in the airways of asthmatic subjects and mice with experimentally induced asthma. All the cardinal features of asthma, including eosinophilic airway inflammation, Th2 cytokine production and bronchial hyper-reactivity, were abrogated when lung ATP levels were locally neutralized using apyrase or when mice were treated with broad-spectrum P2-receptor antagonists. In addition to these effects of ATP in established inflammation, Th2 sensitization to inhaled antigen was enhanced by endogenous or exogenous ATP. The adjuvant effects of ATP were due to the recruitment and activation of lung myeloid dendritic cells that induced Th2 responses in the mediastinal nodes. Together these data show that purinergic signaling has a key role in allergen-driven lung inflammation that is likely to be amenable to therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17632526     DOI: 10.1038/nm1617

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  221 in total

Review 1.  Perspectives of purinergic signaling in stem cell differentiation and tissue regeneration.

Authors:  Talita Glaser; Angélica Regina Cappellari; Micheli Mainardi Pillat; Isabele Cristiana Iser; Márcia Rosângela Wink; Ana Maria Oliveira Battastini; Henning Ulrich
Journal:  Purinergic Signal       Date:  2011-12-06       Impact factor: 3.765

Review 2.  Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.

Authors:  Kristina Ludigs; Valeriy Parfenov; Renaud A Du Pasquier; Greta Guarda
Journal:  Cell Mol Life Sci       Date:  2012-04-24       Impact factor: 9.261

3.  [Bone marrow hematopoiesis. Evaluation of the myelogram].

Authors:  E B Vladimirskaia
Journal:  Gematol Transfuziol       Date:  1990-08       Impact factor: 0.172

Review 4.  Purinergic signaling: a novel mechanism in immune surveillance.

Authors:  Lin Mei; Wei Du; Wei Gao; Qi-bing Mei
Journal:  Acta Pharmacol Sin       Date:  2010-08-16       Impact factor: 6.150

5.  Isolation and identification of ATP-secreting bacteria from mice and humans.

Authors:  Tadayuki Iwase; Hitomi Shinji; Akiko Tajima; Fumiya Sato; Taku Tamura; Takeo Iwamoto; Minoru Yoneda; Yoshimitsu Mizunoe
Journal:  J Clin Microbiol       Date:  2010-03-19       Impact factor: 5.948

Review 6.  The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases.

Authors:  Luca Antonioli; Corrado Blandizzi; Pál Pacher; György Haskó
Journal:  Pharmacol Rev       Date:  2019-07       Impact factor: 25.468

7.  Extracellular ATP mediates the late phase of neutrophil recruitment to the lung in murine models of acute lung injury.

Authors:  Dilip Shah; Freddy Romero; William Stafstrom; Michelle Duong; Ross Summer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-11-27       Impact factor: 5.464

8.  Attenuated allergic airway inflammation in Cd39 null mice.

Authors:  M Idzko; C K Ayata; T Müller; T Dürk; M Grimm; K Baudiß; R P Vieira; S Cicko; C Boehlke; A Zech; S Sorichter; J Pelletier; J Sévigny; S C Robson
Journal:  Allergy       Date:  2013-03-01       Impact factor: 13.146

9.  Human P2Y(14) receptor agonists: truncation of the hexose moiety of uridine-5'-diphosphoglucose and its replacement with alkyl and aryl groups.

Authors:  Arijit Das; Hyojin Ko; Lauren E Burianek; Matthew O Barrett; T Kendall Harden; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2010-01-14       Impact factor: 7.446

10.  Concentration-dependent noncysteinyl leukotriene type 1 receptor-mediated inhibitory activity of leukotriene receptor antagonists.

Authors:  Grzegorz Woszczek; Li-Yuan Chen; Sara Alsaaty; Sahrudaya Nagineni; James H Shelhamer
Journal:  J Immunol       Date:  2010-01-18       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.